Symbols / NVO Stock $42.81 +1.47% Novo Nordisk A/S

Healthcare • Drug Manufacturers - General • Denmark • NYQ
NVO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - General
CEO Mr. Maziar Mike Doustdar B.A.
Exch · Country NYQ · Denmark
Market Cap 189.61B
Enterprise Value 312.19B
Income 121.96B
Sales 327.80B
FCF (ttm) -12.04B
Book/sh 7.10
Cash/sh 4.87
Employees 67,900
Insider 10d —
IPO Apr 30, 1981
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 42.59%
P/E 10.05
Forward P/E 12.93
PEG 3.07
P/S 0.58
P/B 6.03
P/C —
EV/EBITDA 1.79
EV/Sales 0.95
Quick Ratio 0.54
Current Ratio 0.79
Debt/Eq 72.09
LT Debt/Eq —
EPS (ttm) 4.26
EPS next Y 3.31
EPS Growth 67.10%
Revenue Growth 24.00%
EPS Gr Q/Q 67.20%
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-05
ROA 19.25%
ROE 71.40%
ROIC —
Gross Margin 83.20%
Oper. Margin 61.57%
Profit Margin 37.21%
Shs Outstand 3.35B
Shs Float 3.19B
Insider Own 0.01%
Instit Own 9.83%
Short Float 0.71%
Short Ratio 1.45
Short Interest 22.68M
52W High 81.44
vs 52W High -47.43%
52W Low 35.12
vs 52W Low 21.90%
Beta 0.35
Impl. Vol. 41.60%
Rel Volume 1.02
Avg Volume 16.14M
Volume 16.51M
Target (mean) $47.13
Tgt Median $45.46
Tgt Low $39.95
Tgt High $63.66
# Analysts 12
Recom Buy
Prev Close $42.19
Price $42.81
Change 1.47%
About

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$47.14
Mean price target
2. Current target
$42.81
Latest analyst target
3. DCF / Fair value
$-64.61
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$42.81
Low
$39.96
High
$63.67
Mean
$47.14

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-02 down Goldman Sachs Buy → Neutral $41
2026-02-24 down JP Morgan Overweight → Neutral —
2026-01-09 init CICC — → Outperform $74
2025-12-08 down Argus Research Buy → Hold —
2025-11-28 main Goldman Sachs Buy → Buy $54
2025-11-25 main BMO Capital Market Perform → Market Perform $46
2025-11-24 down HSBC Buy → Hold —
2025-10-14 main BMO Capital Market Perform → Market Perform $55
2025-10-02 up HSBC Hold → Buy $70
2025-09-29 down Morgan Stanley Equal-Weight → Underweight $47
2025-09-17 up Berenberg Hold → Buy —
2025-08-19 main TD Cowen Buy → Buy $70
2025-08-05 down UBS Buy → Neutral —
2025-07-31 down HSBC Buy → Hold —
2025-07-30 down Barclays Overweight → Equal-Weight —
2025-06-18 reit TD Cowen Buy → Buy $105
2025-04-17 down BMO Capital Outperform → Market Perform $64
2025-01-08 up UBS Sell → Buy —
2024-12-23 main BMO Capital Outperform → Outperform $105
2024-11-06 reit Cantor Fitzgerald Overweight → Overweight $160
News
RSS: Latest NVO news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
309,064.00
+6.43%
290,403.00
+25.03%
232,261.00
+31.26%
176,954.00
Operating Revenue
729,423.00
+7.18%
680,563.00
+11.82%
608,645.00
+33.56%
455,692.00
Cost Of Revenue
58,788.00
+32.04%
44,522.00
+24.48%
35,765.00
+25.72%
28,448.00
Reconciled Cost Of Revenue
58,788.00
+32.04%
44,522.00
+24.48%
35,765.00
+25.72%
28,448.00
Gross Profit
250,276.00
+1.79%
245,881.00
+25.13%
196,496.00
+32.32%
148,506.00
Operating Expense
122,618.00
+4.32%
117,542.00
+25.15%
93,922.00
+27.44%
73,697.00
Research And Development
52,039.00
+8.27%
48,062.00
+48.14%
32,443.00
+34.91%
24,047.00
Selling General And Administration
70,279.00
+4.31%
67,377.00
+9.38%
61,598.00
+21.53%
50,684.00
Selling And Marketing Expense
64,310.00
+3.56%
62,101.00
+9.44%
56,743.00
+22.78%
46,217.00
General And Administrative Expense
5,969.00
+13.13%
5,276.00
+8.67%
4,855.00
+8.69%
4,467.00
Other Gand A
5,969.00
+13.13%
5,276.00
+8.67%
4,855.00
+8.69%
4,467.00
Other Operating Expenses
300.00
-85.73%
2,103.00
+1867.23%
-119.00
+88.49%
-1,034.00
Total Expenses
181,406.00
+11.93%
162,064.00
+24.97%
129,687.00
+26.96%
102,145.00
Operating Income
127,658.00
-0.53%
128,339.00
+25.12%
102,574.00
+37.11%
74,809.00
Total Operating Income As Reported
127,658.00
-0.53%
128,339.00
+25.12%
102,574.00
+37.11%
74,809.00
EBITDA
156,729.00
+5.94%
147,938.00
+29.06%
114,629.00
+49.25%
76,802.00
Normalized EBITDA
150,651.00
+1.12%
148,978.00
+31.91%
112,940.00
+37.66%
82,040.00
Reconciled Depreciation
21,982.00
+15.05%
19,107.00
+102.99%
9,413.00
+27.86%
7,362.00
EBIT
134,747.00
+4.59%
128,831.00
+22.44%
105,216.00
+51.52%
69,440.00
Total Unusual Items
6,078.00
+684.42%
-1,040.00
-161.57%
1,689.00
+132.25%
-5,238.00
Total Unusual Items Excluding Goodwill
6,078.00
+684.42%
-1,040.00
-161.57%
1,689.00
+132.25%
-5,238.00
Net Income
102,434.00
+1.43%
100,988.00
+20.68%
83,683.00
+50.71%
55,525.00
Pretax Income
130,540.00
+2.63%
127,191.00
+21.51%
104,674.00
+51.57%
69,062.00
Net Non Operating Interest Income Expense
-3,179.00
-3393.41%
-91.00
-127.58%
330.00
+203.13%
-320.00
Interest Expense Non Operating
4,207.00
+156.52%
1,640.00
+202.58%
542.00
+43.39%
378.00
Net Interest Income
-3,179.00
-3393.41%
-91.00
-127.58%
330.00
+203.13%
-320.00
Interest Expense
4,207.00
+156.52%
1,640.00
+202.58%
542.00
+43.39%
378.00
Interest Income Non Operating
1,269.00
-30.96%
1,838.00
+71.94%
1,069.00
+347.28%
239.00
Interest Income
1,269.00
-30.96%
1,838.00
+71.94%
1,069.00
+347.28%
239.00
Other Income Expense
6,061.00
+673.42%
-1,057.00
-159.72%
1,770.00
+132.61%
-5,427.00
Gain On Sale Of Security
6,078.00
+684.42%
-1,040.00
-161.57%
1,689.00
+132.25%
-5,238.00
Tax Provision
28,106.00
+7.26%
26,203.00
+24.83%
20,991.00
+55.06%
13,537.00
Tax Rate For Calcs
0.00
+4.51%
0.00
+2.49%
0.00
+2.55%
0.00
Tax Effect Of Unusual Items
1,308.63
+710.78%
-214.25
-163.11%
339.49
+133.07%
-1,026.65
Net Income Including Noncontrolling Interests
102,434.00
+1.43%
100,988.00
+20.68%
83,683.00
+50.71%
55,525.00
Net Income From Continuing Operation Net Minority Interest
102,434.00
+1.43%
100,988.00
+20.68%
83,683.00
+50.71%
55,525.00
Net Income From Continuing And Discontinued Operation
102,434.00
+1.43%
100,988.00
+20.68%
83,683.00
+50.71%
55,525.00
Net Income Continuous Operations
102,434.00
+1.43%
100,988.00
+20.68%
83,683.00
+50.71%
55,525.00
Normalized Income
97,664.63
-4.08%
101,813.75
+23.66%
82,333.49
+37.83%
59,736.35
Net Income Common Stockholders
102,434.00
+1.43%
100,988.00
+20.68%
83,683.00
+50.71%
55,525.00
Diluted EPS
23.03
+1.77%
22.63
+21.54%
18.62
+52.37%
12.22
Basic EPS
23.06
+1.72%
22.67
+21.42%
18.67
+52.28%
12.26
Basic Average Shares
4,442.06
-0.27%
4,453.90
-0.64%
4,482.80
-1.06%
4,530.60
Diluted Average Shares
4,447.85
-0.34%
4,463.00
-0.71%
4,494.80
-1.10%
4,544.60
Diluted NI Availto Com Stockholders
102,434.00
+1.43%
100,988.00
+20.68%
83,683.00
+50.71%
55,525.00
Earnings From Equity Interest
-17.00
+0.00%
-17.00
-120.99%
81.00
+142.86%
-189.00
Total Other Finance Cost
241.00
-16.61%
289.00
+46.70%
197.00
+8.84%
181.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
542,902.00
+16.60%
465,630.00
+48.06%
314,486.00
+30.35%
241,257.00
Current Assets
172,453.00
+6.59%
161,788.00
+15.86%
139,646.00
+29.07%
108,194.00
Cash Cash Equivalents And Short Term Investments
26,962.00
+2.49%
26,308.00
-12.97%
30,230.00
+28.23%
23,574.00
Cash And Cash Equivalents
26,464.00
+69.05%
15,655.00
+8.78%
14,392.00
+13.74%
12,653.00
Cash Financial
26,464.00
+69.05%
15,655.00
+8.78%
14,392.00
+13.74%
12,653.00
Other Short Term Investments
498.00
-95.33%
10,653.00
-32.74%
15,838.00
+45.02%
10,921.00
Receivables
89,186.00
+1.00%
88,305.00
+17.33%
75,261.00
+30.88%
57,505.00
Accounts Receivable
70,856.00
-1.52%
71,949.00
+11.08%
64,770.00
+28.11%
50,560.00
Gross Accounts Receivable
72,843.00
-1.66%
74,076.00
+11.29%
66,564.00
+27.81%
52,080.00
Allowance For Doubtful Accounts Receivable
-1,987.00
+6.58%
-2,127.00
-18.56%
-1,794.00
-18.03%
-1,520.00
Other Receivables
13,482.00
-0.16%
13,503.00
+67.36%
8,068.00
+34.35%
6,005.00
Taxes Receivable
4,848.00
+69.93%
2,853.00
+17.75%
2,423.00
+157.77%
940.00
Inventory
49,623.00
+21.48%
40,849.00
+28.41%
31,811.00
+30.44%
24,388.00
Raw Materials
17,436.00
+30.42%
13,369.00
+40.73%
9,500.00
+48.62%
6,392.00
Work In Process
25,858.00
+15.77%
22,335.00
+26.90%
17,601.00
+28.73%
13,673.00
Finished Goods
11,990.00
+35.13%
8,873.00
+22.83%
7,224.00
+19.64%
6,038.00
Hedging Assets Current
6,682.00
+5.63%
6,326.00
+169.88%
2,344.00
-14.04%
2,727.00
Total Non Current Assets
370,449.00
+21.92%
303,842.00
+73.78%
174,840.00
+31.40%
133,063.00
Net PPE
208,378.00
+28.88%
161,680.00
+77.75%
90,961.00
+36.43%
66,671.00
Gross PPE
267,314.00
+24.87%
214,076.00
+54.47%
138,583.00
+24.37%
111,426.00
Accumulated Depreciation
-58,936.00
-12.48%
-52,396.00
-10.02%
-47,622.00
-6.41%
-44,755.00
Properties
65,559.00
+6.82%
61,374.00
+25.28%
48,990.00
+12.87%
43,403.00
Machinery Furniture Equipment
60,020.00
+5.23%
57,039.00
+39.29%
40,951.00
+9.06%
37,548.00
Construction In Progress
130,622.00
+52.78%
85,497.00
+115.56%
39,663.00
+77.38%
22,361.00
Other Properties
11,113.00
+9.32%
10,166.00
+13.22%
8,979.00
+10.66%
8,114.00
Goodwill And Other Intangible Assets
130,053.00
+17.35%
110,821.00
+83.46%
60,406.00
+18.58%
50,939.00
Goodwill
19,845.00
-0.86%
20,017.00
+348.41%
4,464.00
-3.27%
4,615.00
Other Intangible Assets
110,208.00
+21.37%
90,804.00
+62.32%
55,942.00
+20.76%
46,324.00
Investments And Advances
2,507.00
-6.35%
2,677.00
+60.97%
1,663.00
+23.83%
1,343.00
Long Term Equity Investment
366.00
-8.50%
400.00
-2.44%
410.00
+25.38%
327.00
Non Current Accounts Receivable
5,864.00
+46.02%
4,016.00
+180.84%
1,430.00
+594.17%
206.00
Non Current Deferred Assets
23,647.00
-4.06%
24,648.00
+20.94%
20,380.00
+46.58%
13,904.00
Non Current Deferred Taxes Assets
23,647.00
-4.06%
24,648.00
+20.94%
20,380.00
+46.58%
13,904.00
Total Liabilities Net Minority Interest
348,855.00
+8.29%
322,144.00
+54.93%
207,925.00
+31.79%
157,771.00
Current Liabilities
215,661.00
-0.90%
217,614.00
+28.27%
169,655.00
+40.28%
120,940.00
Payables And Accrued Expenses
161,523.00
+0.13%
161,309.00
+392.97%
32,722.00
+44.29%
22,678.00
Payables
161,523.00
+0.13%
161,309.00
+392.97%
32,722.00
+44.29%
22,678.00
Accounts Payable
153,107.00
+1.00%
151,593.00
+492.02%
25,606.00
+64.28%
15,587.00
Employee Benefits
861.00
-4.65%
903.00
+21.70%
742.00
-2.62%
762.00
Total Tax Payable
8,416.00
-13.38%
9,716.00
+36.54%
7,116.00
+0.35%
7,091.00
Current Debt And Capital Lease Obligation
12,017.00
-8.36%
13,113.00
+102.42%
6,478.00
+341.88%
1,466.00
Current Debt
10,681.00
-9.29%
11,775.00
+122.00%
5,304.00
+1005.00%
480.00
Other Current Borrowings
9,753.00
+63.01%
5,983.00
+23.41%
4,848.00
—
Current Capital Lease Obligation
1,336.00
-0.15%
1,338.00
+13.97%
1,174.00
+19.07%
986.00
Other Current Liabilities
41,747.00
-2.69%
42,903.00
+43.12%
29,977.00
+13.08%
26,509.00
Total Non Current Liabilities Net Minority Interest
133,194.00
+27.42%
104,530.00
+173.14%
38,270.00
+3.91%
36,831.00
Long Term Debt And Capital Lease Obligation
118,941.00
+32.64%
89,674.00
+336.84%
20,528.00
-15.59%
24,318.00
Long Term Debt
111,705.00
+32.59%
84,246.00
+427.33%
15,976.00
-23.10%
20,775.00
Long Term Capital Lease Obligation
7,236.00
+33.31%
5,428.00
+19.24%
4,552.00
+28.48%
3,543.00
Long Term Provisions
5,730.00
-17.93%
6,982.00
+5.01%
6,649.00
+44.86%
4,590.00
Non Current Pension And Other Postretirement Benefit Plans
861.00
-4.65%
903.00
+21.70%
742.00
-2.62%
762.00
Tradeand Other Payables Non Current
1,051.00
-27.82%
1,456.00
+670.37%
189.00
+89.00%
100.00
Non Current Deferred Liabilities
6,611.00
+19.87%
5,515.00
-45.73%
10,162.00
+43.92%
7,061.00
Non Current Deferred Taxes Liabilities
6,611.00
+19.87%
5,515.00
-45.73%
10,162.00
+43.92%
7,061.00
Other Non Current Liabilities
—
23.00
-87.83%
189.00
+89.00%
100.00
Stockholders Equity
194,047.00
+35.24%
143,486.00
+34.65%
106,561.00
+27.64%
83,486.00
Common Stock Equity
194,047.00
+35.24%
143,486.00
+34.65%
106,561.00
+27.64%
83,486.00
Capital Stock
446.00
+0.00%
446.00
-1.11%
451.00
-1.10%
456.00
Common Stock
446.00
+0.00%
446.00
-1.11%
451.00
-1.10%
456.00
Share Issued
4,465.00
+0.00%
4,465.00
-1.00%
4,510.00
-1.10%
4,560.00
Ordinary Shares Number
4,443.48
+0.05%
4,441.34
-0.38%
4,458.29
-0.92%
4,499.80
Treasury Shares Number
21.52
-9.04%
23.66
-54.25%
51.71
-14.10%
60.20
Retained Earnings
195,298.00
+35.20%
144,448.00
+37.78%
104,839.00
+30.09%
80,587.00
Gains Losses Not Affecting Retained Earnings
-1,695.00
-20.55%
-1,406.00
-210.19%
1,276.00
-47.90%
2,449.00
Treasury Stock
2.00
+0.00%
2.00
-60.00%
5.00
-16.67%
6.00
Other Equity Adjustments
-1,695.00
-20.55%
-1,406.00
-210.19%
1,276.00
-47.90%
2,449.00
Total Equity Gross Minority Interest
194,047.00
+35.24%
143,486.00
+34.65%
106,561.00
+27.64%
83,486.00
Total Capitalization
305,752.00
+34.26%
227,732.00
+85.85%
122,537.00
+17.53%
104,261.00
Working Capital
-43,208.00
+22.60%
-55,826.00
-86.03%
-30,009.00
-135.44%
-12,746.00
Invested Capital
316,433.00
+32.12%
239,507.00
+87.35%
127,841.00
+22.05%
104,741.00
Total Debt
130,958.00
+27.41%
102,787.00
+280.61%
27,006.00
+4.74%
25,784.00
Net Debt
95,922.00
+19.36%
80,366.00
+1066.75%
6,888.00
-19.93%
8,602.00
Capital Lease Obligations
8,572.00
+26.69%
6,766.00
+18.16%
5,726.00
+26.43%
4,529.00
Net Tangible Assets
63,994.00
+95.91%
32,665.00
-29.23%
46,155.00
+41.81%
32,547.00
Tangible Book Value
63,994.00
+95.91%
32,665.00
-29.23%
46,155.00
+41.81%
32,547.00
Available For Sale Securities
2,141.00
-5.97%
2,277.00
+81.72%
1,253.00
+23.33%
1,016.00
Commercial Paper
745.00
-86.06%
5,343.00
0.00
—
Current Notes Payable
—
—
—
0.00
Current Provisions
374.00
+29.41%
289.00
-99.71%
100,478.00
+42.95%
70,287.00
Inventories Adjustments Allowances
-5,661.00
-51.85%
-3,728.00
-48.29%
-2,514.00
-46.59%
-1,715.00
Investmentin Financial Assets
2,141.00
-5.97%
2,277.00
+81.72%
1,253.00
+23.33%
1,016.00
Investmentsin Associatesat Cost
366.00
-8.50%
400.00
-2.44%
410.00
+25.38%
327.00
Line Of Credit
183.00
-59.24%
449.00
-1.54%
456.00
-5.00%
480.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
119,102.00
-1.54%
120,968.00
+11.07%
108,908.00
+38.06%
78,887.00
Cash Flow From Continuing Operating Activities
119,102.00
-1.54%
120,968.00
+11.07%
108,908.00
+38.06%
78,887.00
Net Income From Continuing Operations
102,434.00
+1.43%
100,988.00
+20.68%
83,683.00
+50.71%
55,525.00
Depreciation Amortization Depletion
21,982.00
+15.05%
19,107.00
+102.99%
9,413.00
+27.86%
7,362.00
Depreciation
21,982.00
+15.05%
19,107.00
+102.99%
9,413.00
+27.86%
7,362.00
Amortization Cash Flow
—
2,512.00
—
1,599.00
Depreciation And Amortization
21,982.00
+15.05%
19,107.00
+102.99%
9,413.00
+27.86%
7,362.00
Amortization Of Intangibles
—
2,512.00
—
1,599.00
Other Non Cash Items
-3,122.00
-801.57%
445.00
+4.95%
424.00
-82.09%
2,367.00
Pension And Employee Benefit Expense
—
-119.00
-100.37%
32,243.00
+5142.76%
615.00
Stock Based Compensation
—
2,289.00
+6.51%
2,149.00
+39.64%
1,539.00
Provisionand Write Offof Assets
—
21,030.00
-34.75%
32,230.00
+74.55%
18,465.00
Asset Impairment Charge
—
10,562.00
—
809.00
Deferred Tax
28,106.00
+7.26%
26,203.00
+24.83%
20,991.00
+55.06%
13,537.00
Deferred Income Tax
28,106.00
+7.26%
26,203.00
+24.83%
20,991.00
+55.06%
13,537.00
Operating Gains Losses
—
-11,027.00
-134.17%
32,268.00
+23282.61%
138.00
Gain Loss On Investment Securities
—
-5,079.00
-4891.51%
106.00
-95.88%
2,572.00
Net Foreign Currency Exchange Gain Loss
—
-5,846.00
-356.74%
2,277.00
+170.32%
-3,238.00
Change In Working Capital
3,737.00
+44.34%
2,589.00
-86.87%
19,713.00
+456.15%
-5,535.00
Change In Receivables
—
-14,309.00
+12.07%
-16,273.00
-50.34%
-10,824.00
Changes In Account Receivables
—
-7,179.00
+49.48%
-14,210.00
-43.29%
-9,917.00
Change In Inventory
—
-9,038.00
-21.76%
-7,423.00
-55.72%
-4,767.00
Change In Payables And Accrued Expense
—
-280.00
-103.69%
7,587.00
+47.32%
5,150.00
Change In Payable
—
-280.00
-103.69%
7,587.00
+47.32%
5,150.00
Change In Account Payable
—
3,240.00
-67.66%
10,019.00
+49.16%
6,717.00
Change In Other Working Capital
—
2,510.00
+303.24%
-1,235.00
-206.47%
1,160.00
Change In Other Current Liabilities
—
9,122.00
+78.90%
5,099.00
+36.12%
3,746.00
Investing Cash Flow
-79,158.00
+38.59%
-128,895.00
-193.66%
-43,892.00
-76.15%
-24,918.00
Cash Flow From Continuing Investing Activities
-79,158.00
+38.59%
-128,895.00
-193.66%
-43,892.00
-76.15%
-24,918.00
Net PPE Purchase And Sale
-60,140.00
-27.51%
-47,164.00
-82.76%
-25,806.00
-112.47%
-12,146.00
Purchase Of PPE
-60,140.00
-27.51%
-47,164.00
-82.76%
-25,806.00
-112.47%
-12,146.00
Sale Of PPE
—
—
—
0.00
Capital Expenditure
-90,113.00
-75.63%
-51,309.00
-31.91%
-38,896.00
-163.65%
-14,753.00
Net Investment Purchase And Sale
9,951.00
+117.41%
4,577.00
+191.61%
-4,996.00
-61.68%
-3,090.00
Purchase Of Investment
-723.00
+96.35%
-19,814.00
-49.10%
-13,289.00
-36.51%
-9,735.00
Sale Of Investment
10,674.00
-56.24%
24,391.00
+194.12%
8,293.00
+24.80%
6,645.00
Net Business Purchase And Sale
1,004.00
+101.22%
-82,163.00
0.00
+100.00%
-7,075.00
Purchase Of Business
0.00
+100.00%
-82,163.00
0.00
+100.00%
-7,075.00
Net Intangibles Purchase And Sale
-29,973.00
-623.11%
-4,145.00
+68.33%
-13,090.00
-402.11%
-2,607.00
Purchase Of Intangibles
-29,973.00
-623.11%
-4,145.00
+68.33%
-13,090.00
-402.11%
-2,607.00
Financing Cash Flow
-28,408.00
-425.22%
8,735.00
+113.83%
-63,158.00
-21.93%
-51,797.00
Cash Flow From Continuing Financing Activities
-28,408.00
-425.22%
8,735.00
+113.83%
-63,158.00
-21.93%
-51,797.00
Net Issuance Payments Of Debt
24,743.00
-66.13%
73,056.00
+5079.96%
-1,467.00
+39.08%
-2,408.00
Issuance Of Debt
103,931.00
+30.91%
79,391.00
0.00
-100.00%
11,215.00
Repayment Of Debt
-79,188.00
-1150.01%
-6,335.00
-331.83%
-1,467.00
+89.23%
-13,623.00
Long Term Debt Issuance
103,931.00
+30.91%
79,391.00
0.00
-100.00%
11,215.00
Long Term Debt Payments
-79,188.00
-1150.01%
-6,335.00
-331.83%
-1,467.00
+89.23%
-13,623.00
Net Long Term Debt Issuance
24,743.00
-66.13%
73,056.00
+5079.96%
-1,467.00
+39.08%
-2,408.00
Net Common Stock Issuance
-1,388.00
+93.12%
-20,181.00
+32.56%
-29,924.00
-24.24%
-24,086.00
Common Stock Payments
-1,388.00
+93.12%
-20,181.00
+32.56%
-29,924.00
-24.24%
-24,086.00
Cash Dividends Paid
-51,763.00
-17.27%
-44,140.00
-38.95%
-31,767.00
-25.55%
-25,303.00
Repurchase Of Capital Stock
-1,388.00
+93.12%
-20,181.00
+32.56%
-29,924.00
-24.24%
-24,086.00
Changes In Cash
11,536.00
+1327.72%
808.00
-56.51%
1,858.00
-14.46%
2,172.00
Effect Of Exchange Rate Changes
-727.00
-259.78%
455.00
+482.35%
-119.00
+50.00%
-238.00
Beginning Cash Position
15,655.00
+8.78%
14,392.00
+13.74%
12,653.00
+18.04%
10,719.00
End Cash Position
26,464.00
+69.05%
15,655.00
+8.78%
14,392.00
+13.74%
12,653.00
Free Cash Flow
28,989.00
-58.38%
69,659.00
-0.50%
70,012.00
+9.17%
64,134.00
Dividends Received CFI
—
—
0.00
0.00
Earnings Losses From Equity Investments
—
17.00
+120.99%
-81.00
-142.86%
189.00
Interest Paid CFO
-3,419.00
-458.66%
-612.00
-24.64%
-491.00
-80.51%
-272.00
Interest Received CFO
1,398.00
-25.80%
1,884.00
+75.75%
1,072.00
+288.41%
276.00
Sale Of Business
1,004.00
0.00
0.00
—
Taxes Refund Paid
-32,014.00
-8.02%
-29,636.00
-14.44%
-25,897.00
-78.42%
-14,515.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category